Newsquawk Logo

FDA Commissioner Marty Makary is resigning, according to Politico

The resignation of FDA Commissioner Marty Makary could signal potential shifts in regulatory approaches, particularly affecting sectors like biotech and pharmaceuticals.

Newsquawk StaffPublished On the live feed at — 5 more headlines followed before this page went public
Newsquawk headlinesUTC

UK to contribute drones, jets and warship to multinational mission to secure the Strait of Hormuz

Andy Burnham holds secret meeting with MPs in London, Telegraph reports; he consults key supporters as the PM's future hangs in the balance

FDA Commissioner Marty Makary is resigning, according to Politico

UK Deputy PM Lammy says PM Starmer has his full support; no one seems to have enough support to stand up against Starmer

White House on reports that Trump and Xi are considering a deal to allow China to invest USD 1tln in the US to build factories on American soil- "baseless and false.", via News Nation

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
  • Kyle Diamantas will lead the FDA in an acting capacity.
Context

Market participants should watch for how this leadership change may influence policy direction and investor sentiment, especially in equities and related commodities impacted by FDA regulations. Given the market's focus, this development may create volatility in related assets, especially for biotech ETFs and pharmaceuticals.

External

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.